Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Prins

Showing results (711-720 of 722) with videos related to

Pageof 73
Sort By:
Nature Communications|November 21, 2025
HIV-1 envelope trimer vaccine induces sex-associated differences in antibody responses: a phase 1 clinical trialEmma I M M Reiss, Karlijn van der Straten, Laura T M Graus, et al.
Open Forum Infectious Diseases|December 4, 2015
Risk Factors for Sexual Transmission of Hepatitis C Virus Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men: A Case-Control StudyJoost W Vanhommerig, Femke A E Lambers, Janke Schinkel, et al.
Journal of Translational Medicine|July 1, 2018
Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastomaLinda M Liau, Keyoumars Ashkan, David D Tran, et al.
Journal of Translational Medicine|May 31, 2018
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastomaLinda M Liau, Keyoumars Ashkan, David D Tran, et al.
Annals of Surgery|October 6, 2020
Yield of Screening for COVID-19 in Asymptomatic Patients Before Elective or Emergency Surgery Using Chest CT and RT-PCR (SCOUT): Multicenter StudyCarl A J Puylaert, Jochem C G Scheijmans, Alexander B J Borgstein, et al.
JAMA Oncology|November 17, 2022
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort TrialLinda M Liau, Keyoumars Ashkan, Steven Brem, et al.
Science (New York, N.Y.)|May 15, 2025
Precise targeting of HIV broadly neutralizing antibody precursors in humansTom G Caniels, Madhu Prabhakaran, Gabriel Ozorowski, et al.
Journal of Viral Hepatitis|January 7, 2015
The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2A Hatzakis, V Chulanov, A C Gadano, et al.
Journal of Viral Hepatitis|January 7, 2015
Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2E Gane, D Kershenobich, C Seguin-Devaux, et al.
Journal of Viral Hepatitis|January 7, 2015
Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2V Saraswat, S Norris, R J de Knegt, et al.
Pageof 73

Showing results (711-720 of 722) with videos related to

Sort By:
Pageof 73
Nature Communications|November 21, 2025
HIV-1 envelope trimer vaccine induces sex-associated differences in antibody responses: a phase 1 clinical trialEmma I M M Reiss, Karlijn van der Straten, Laura T M Graus, et al.
Open Forum Infectious Diseases|December 4, 2015
Risk Factors for Sexual Transmission of Hepatitis C Virus Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men: A Case-Control StudyJoost W Vanhommerig, Femke A E Lambers, Janke Schinkel, et al.
Journal of Translational Medicine|July 1, 2018
Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastomaLinda M Liau, Keyoumars Ashkan, David D Tran, et al.
Journal of Translational Medicine|May 31, 2018
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastomaLinda M Liau, Keyoumars Ashkan, David D Tran, et al.
Annals of Surgery|October 6, 2020
Yield of Screening for COVID-19 in Asymptomatic Patients Before Elective or Emergency Surgery Using Chest CT and RT-PCR (SCOUT): Multicenter StudyCarl A J Puylaert, Jochem C G Scheijmans, Alexander B J Borgstein, et al.
JAMA Oncology|November 17, 2022
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort TrialLinda M Liau, Keyoumars Ashkan, Steven Brem, et al.
Science (New York, N.Y.)|May 15, 2025
Precise targeting of HIV broadly neutralizing antibody precursors in humansTom G Caniels, Madhu Prabhakaran, Gabriel Ozorowski, et al.
Journal of Viral Hepatitis|January 7, 2015
The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2A Hatzakis, V Chulanov, A C Gadano, et al.
Journal of Viral Hepatitis|January 7, 2015
Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2E Gane, D Kershenobich, C Seguin-Devaux, et al.
Journal of Viral Hepatitis|January 7, 2015
Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2V Saraswat, S Norris, R J de Knegt, et al.
Pageof 73